Naim Abu-Freha
Ben-Gurion University of the Negev
OffspringCancerInternal medicineObstetricsRandomized controlled trialStromal cellPediatricsCohort studyImmunologyClinical endpointVirusDysplasiaHepatitis C virusHepatitis CCirrhosisHepatitis BInflammatory bowel diseaseSofosbuvirColonoscopyDiseasePregnancyCrohn's diseaseUlcerative colitisPolypectomyHepatitis B virusPopulationCancer-Associated FibroblastsSurveillance colonoscopyChronic hepatitisIncidence (epidemiology)PharmacotherapyProportional hazards modelRisk factorColorectal cancerGeneral surgeryMedicineCohortBiologyCumulative incidenceGastroenterology
26Publications
6H-index
113Citations
Publications 26
Newest
#1Naim Abu-Freha (BGU: Ben-Gurion University of the Negev)H-Index: 6
#2Lior H. Katz (HUJI: Hebrew University of Jerusalem)H-Index: 22
Last. Zohar Levi (TAU: Tel Aviv University)H-Index: 28
view all 8 authors...
BACKGROUND Recently, three updated guidelines for post-polypectomy colonoscopy surveillance (PPCS) have been published. These guidelines are based on a comprehensive summary of the literature, while some recommendations are similar, different surveillance intervals are recommended after detection of specific types of polyps. AIM In this review, we aimed to compare and contrast these recommendations. METHODS The updated guidelines for PPCS were reviewed and the recommendations were compared. RESU...
Source
#1Naim Abu-FrehaH-Index: 6
#2Roni GatH-Index: 2
Last. Ohad EtzionH-Index: 14
view all 9 authors...
Sex and gender can affect the prevalence and prognosis of diseases. Our aim was to assess similarities and differences for males and females who underwent an upper endoscopy, with regards to indications and results. We reviewed all upper endoscopy reports from 2012 to 2016. Data regarding demographics, indications, and procedure findings were collected. The upper endoscopy findings were compared regarding the most common indications: gastroesophageal reflux, abdominal pain, gastrointestinal blee...
Source
#1Naim Abu-Freha (BGU: Ben-Gurion University of the Negev)H-Index: 6
#2Tama Wainstock (BGU: Ben-Gurion University of the Negev)
Last. Eyal Sheiner (BGU: Ben-Gurion University of the Negev)H-Index: 71
view all 4 authors...
We investigated whether maternal hepatitis B virus (HBV) or hepatitis C virus (HCV) carrier status increases the risk for long-term oncologic morbidity of their offspring up to the age of 18 years. A population-based cohort study was conducted, including all singleton deliveries between the years 1991-2014 at a tertiary medical center. Our study included: HBV carriers (n = 588), HCV carriers (n = 183) and non-carriers (n = 241570. No significant differences regarding oncologic morbidity were fou...
Source
#1Naim Abu-Freha (BGU: Ben-Gurion University of the Negev)H-Index: 6
#2Tamar Wainstock (BGU: Ben-Gurion University of the Negev)H-Index: 16
Last. Eyal Sheiner (BGU: Ben-Gurion University of the Negev)H-Index: 71
view all 4 authors...
PROBLEM celiac disease is an autoimmune disease, patients with celiac have increased risk for infections and offspring of celiac mothers have increased morbidity. The aim of the study was to assess long-term infectious morbidity among offspring of pregnant women with celiac disease. METHOD OF STUDY A population-based cohort study was conducted, including all singleton deliveries between the years 1991-2014 at a tertiary medical center. The offsprings were subdivided into two groups: offsprings o...
Source
#1Israel Yoles (BGU: Ben-Gurion University of the Negev)H-Index: 3
#1Israel Yoles (BGU: Ben-Gurion University of the Negev)H-Index: 2
Last. Tamar Wainstock (BGU: Ben-Gurion University of the Negev)H-Index: 16
view all 4 authors...
Hepatitis B and hepatitis C (HBV/HCV) are important global public health concerns. We aimed to evaluate the association between maternal HBV/HCV carrier status and long-term offspring neurological hospitalisations. A population-based cohort analysis compared the risk for long-term childhood neurological hospitalisations in offspring born to HBV/HCV carrier vs. non-carrier mothers in a large tertiary medical centre between 1991 and 2014. Childhood neurological diseases, such as cerebral palsy, mo...
Source
#1Ohad EtzionH-Index: 14
#2Harel Dahari (LUC: Loyola University Chicago)H-Index: 31
Last. Amir Shlomai (Rabin Medical Center)H-Index: 22
view all 19 authors...
The advent of direct-acting antivirals (DAAs) has transformed the landscape of hepatitis C virus (HCV) management. We aimed to prospectively (real-time) evaluate the feasibility of using a response-guided therapy approach, based on mathematical modeling of early viral kinetics, to reduce the duration of DAAs therapy. Patients were treated with DAAs according to the physicians’ preference. HCV was measured at baseline and at day 2 and weeks 1, 2 and 4 after treatment initiation. The primary endpo...
Source
#1Naim Abu-FrehaH-Index: 6
#2Muhammad Abu Tailakh (BGU: Ben-Gurion University of the Negev)H-Index: 6
Last. Ohad EtzionH-Index: 14
view all 9 authors...
Adherence to treatment of chronic Hepatitis B Virus (HBV) is an important issue and can affect the complication rate. Nucleos(t)ide analogue as oral treatments are used for patients with necro-inflammatory activity and high viral load, with the goal of decline the complication rate such cirrhosis and hepatic cancer. We aimed to investigate the adherence to chronic HBV treatment. Chronic HBV patients with dispensing medication rates (DMR) of at least 80% were defined as high adherence group (HAG)...
Source
1 CitationsSource
#1Naim Abu-Freha (BGU: Ben-Gurion University of the Negev)H-Index: 6
#2Muhammad Abu Tailakh (BGU: Ben-Gurion University of the Negev)H-Index: 6
Last. Ohad Etzion (BGU: Ben-Gurion University of the Negev)H-Index: 14
view all 8 authors...
Source
#1Ohad EtzionH-Index: 14
#2Harel Dahari (LUC: Loyola University Chicago)H-Index: 31
Last. Amir Shlomai (Rabin Medical Center)H-Index: 22
view all 19 authors...
Background: The advent of direct-acting antivirals (DAAs) has transformed the landscape of hepatitis C virus (HCV) management. However, the high cost of DAAs therapy has become a major barrier to HCV elimination. We aimed to prospectively evaluate the efficacy and safety of reducing the duration of DAAs therapy using response-guided therapy approach based on mathematical modeling of viral kinetics. Methods: Patients were treated with DAAs according to the physicians’ preference. HCV was measured...
Source